Cover Image
Market Research Report

Global Rapid Influenza Diagnostic Tests Market 2017-2021

Published by TechNavio (Infiniti Research Ltd.) Product code 551757
Published Content info 74 Pages
Delivery time: 1-2 business days
Back to Top
Global Rapid Influenza Diagnostic Tests Market 2017-2021
Published: August 28, 2017 Content info: 74 Pages

About Rapid Influenza Diagnostic Tests

RIDT is an antigen-based diagnostic test used for diagnosis of influenza virus infections in point-of-care (POC) settings. It employs lateral flow technique called immunochromatographic assays. RIDTs are available in the market in the form of a dipstick, card, and cassette. The instrument completes the test in less than 30 minutes and is commonly used for the diagnosis of influenza infections. Based on product type, global RIDTs market is segmented into RIDTs for influenza A and RIDTs for influenza B.

Technavio's analysts forecast the global rapid influenza diagnostic tests market to grow at a CAGR of 9.06% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global rapid influenza diagnostic tests market for 2017-2021. To calculate the market size, the report considers revenue generated by the sales of RIDTs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Rapid Influenza Diagnostic Tests Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Alere
  • BD
  • Quidel

Other Prominent Vendors

  • bioMerieux
  • CorisBioconcept
  • Meridian Bioscience
  • Response Biomedical (acquired by OrbiMed)
  • Princeton BioMeditech Corporation
  • SA Scientific
  • Sekisui Diagnostics
  • Thermo Fisher Scientific

Market driver

  • Government initiatives to control and prevent influenza
  • For a full, detailed list, view our report

Market challenge

  • Product safety features of the test kits
  • For a full, detailed list, view our report

Market trend

  • Rising technological advancements in diagnostics
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR14599

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Market overview
  • RIDTs for influenza A
  • RIDTs for influenza B

PART 07: Market segmentation by end-user

  • Market overview
  • Hospitals and diagnostic laboratories
  • Academic and research centers
  • Homecare

PART 08: Geographical segmentation

  • Market overview
  • RIDTs market in Americas
  • RIDTs market in EMEA
  • RIDTs market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Rising technological advancements in diagnostics
  • Increasing R&D investment

PART 12: Vendor landscape

  • Competitive landscape
  • Other prominent vendors

PART 13: Key vendor analysis

  • Alere
  • BD
  • Quidel

PART 14: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global RIDTs market 2016-2021 ($ billions)
  • Exhibit 02: Five forces analysis
  • Exhibit 03: Global RIDTs market for influenza A 2016-2021 ($ billions)
  • Exhibit 04: Global RIDTs market for influenza B 2016-2021 ($ billions)
  • Exhibit 05: Segmentation of global RIDTs market by end-users 2016 (%)
  • Exhibit 06: Segmentation of global RIDTs market by end-users 2021 (%)
  • Exhibit 07: Global RIDTs market for hospitals and diagnostic laboratories 2016-2021 ($ billions)
  • Exhibit 08: Global RIDTs market for academic and research institutes 2016-2021 ($ billions)
  • Exhibit 09: Global RIDTs market for homecare 2016-2021 ($ billions)
  • Exhibit 10: Segmentation of global RIDTs market by geography 2016 (%)
  • Exhibit 11: Segmentation of global RIDTs market by geography 2021 (%)
  • Exhibit 12: RIDTs market overview in US
  • Exhibit 13: RIDTs market in Americas 2016-2021 ($ billions)
  • Exhibit 14: RIDTs market overview in UK
  • Exhibit 15: RIDTs market in EMEA 2016-2021 ($ billions)
  • Exhibit 16: RIDTs market overview in the Japan.
  • Exhibit 17: RIDTs market in APAC 2016-2021 ($ billions)
  • Exhibit 18: Factors driving the growth of POCT
  • Exhibit 19: People who are at high risk of influenza infection
  • Exhibit 20: Alere: Key highlights
  • Exhibit 21: Alere: Strength assessment
  • Exhibit 22: Alere: Strategy assessment
  • Exhibit 23: Alere: Opportunity assessment
  • Exhibit 24: BD: Key highlights
  • Exhibit 25: BD: Strength assessment
  • Exhibit 26: BD: Strategy assessment
  • Exhibit 27: BD: Opportunity assessment
  • Exhibit 28: Quidel: Key highlights
  • Exhibit 29: Quidel: Strength assessment
  • Exhibit 30: Quidel: Strategy assessment
  • Exhibit 31: Quidel: Opportunity assessment
Back to Top